IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
Taylor Harper(Center for Drug Evaluation and Research), Gerald M. Feldman(Center for Drug Evaluation and Research)
Cited by 8
Related Papers
No related papers found
Powered by citation graph analysis